Sign in Create account

Kovai Medical Center & Hospital Limited

Healthcare · Healthcare Services

NSE: KOVAI BSE: 523323
₹6007.00
▼ -6.50 (-0.11%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
80/100
Strong
Valuation
45/100
Fairly Valued
Momentum
32/100
Neutral

QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹6,573 Cr
PE (TTM)
25.6
Industry median 50.2 (44 companies)
Price to Book
5.0
PEG (TTM)
1.6
Institutions holding %
5.50%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
4.9
Relative return vs Sector, qtr %
2.1
Free Cash Flow
₹110 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
20.73%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
16.29%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
14.96%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
20.72%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
15.35%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.29
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.28
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
12.05
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
16.02%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
23.08%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
22.61%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
11.83%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
20.57%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
18.53%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

7 of 7 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.28)
  • Yes Return on equity is 15% or more (18.5%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.1%
Low 5981.0000 · High 6075.5000
1W return
-2.5%
Low 5974.0000 · High 6199.0000
1M return
-1.1%
Low 5930.5000 · High 6444.0000
52W return
133.1%
Low 5275.5000 · High 6444.0000
Lifetime High ₹6292.0000 (Sept. 10, 2026)
Lifetime Low ₹91.0000 (June 1, 2012)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
6045.5
10D
6076.5
20D
6083.2
50D
5993.4
100D
5572.0
200D
4447.0

Delivery and volume

Day avg. delivery
64.1%
Week avg. delivery
62.8%
Month avg. delivery
61.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

6021.17
Pivot
First resistance6061.33
Second resistance6115.67
Third resistance6155.83
First support5966.83
Second support5926.67
Third support5872.33
Day RSI45.3
Day MFI46.5
Day MACD6.83
Day MACD signal29.84

Beta

1M0.98
3M0.67
1Y0.51
3Y0.60

Price change analysis

↓ -1.1%
Over 1 Month
LowHigh
5930.506444.00
↓ -0.7%
Over 3 Months
LowHigh
5670.506444.00
↑ 133.1%
Over 6 Months
LowHigh
5275.506444.00
↑ 133.1%
Over 1 Year
LowHigh
5275.506444.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 25.6 (own history: 11.5–25.6)
Overvalued (above its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹431 Cr
Net profit (June 30, 2026)
₹69 Cr
Basic EPS (June 30, 2026)
₹63.1400

Ranks #21 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter56.52%
  • Mutual funds3.03%
  • FII/FPI1.25%
  • Other DII1.22%
  • Public37.98%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 56.52% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 1.20% to 1.25% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 3.12% to 3.03% in Jun 2026 qtr

2 mutual fund schemes also hold this stock.

All shareholding details →

Deals (Bulk & Block)

All 24 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
1 Feb 2024 QUANT MUTUAL FUND Bulk Buy 73,400 3201.0000 BSE
1 Feb 2024 AUBURN LIMITED Bulk Sell 147,133 3201.0200 BSE
3 Aug 2021 RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED Bulk Buy 25,515 1494.0500 BSE
3 Aug 2021 RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED Bulk Sell 74,435 1521.6800 BSE
24 Sep 2019 RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED Bulk Buy 63,460 680.0000 BSE
9 Sep 2011 THAVAMANI D PALANISWAMI MRS Bulk Buy 59,524 118.7800 NSE
9 Sep 2011 NATARAJAH PILLAI SUBBIAH Bulk Sell 60,024 118.7800 NSE
26 Oct 2010 DINESH RAJ SHARMA Bulk Sell 62,720 157.8300 NSE
26 Oct 2010 DINESH RAJ SHARMA Bulk Buy 62,720 156.2600 NSE
4 Dec 2006 GRISHMA DHARMESH BUSA Bulk Buy 61,000 57.6800 BSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹15.00 per share
Dividend yield 0.25%
Ex-dateSubjectPer share (₹)Record date
19 Aug 2026 Dividend - Rs 15 Per Share 15.0000 19 Aug 2026
11 Aug 2023 Dividend - Rs 5 Per Share/Special Dividend - Rs 5 Per Share 5.0000 11 Aug 2023
25 Aug 2022 Annual General Meeting/Dividend - Rs 3 Per Share/Special Dividend Rs 3 Per Share 3.0000 —
2 Sep 2021 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 —
25 Aug 2014 Annual General Meeting / Final Dividend - Rs 1.50/- Per Share 1.5000 —
11 Jul 2013 Annual General Meeting And Dividend Rs.1.50 Per Share 1.5000 —
11 Aug 2011 Annual General Meeting And Dividend Rs 1.25 Per Share 1.2500 —
29 Jul 2010 Annual General Meeting And Dividend Rs.1.25 Per Share 1.2500 —

Corporate Actions

Full history (10 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
11 Aug 2023OTHERAnnual General Meeting
28 Jun 2012OTHERAnnual General Meeting / Div Of Rs. 1.25/- Per Share

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
31 Oct 2014 Results Yes
17 Jul 2014 Results Yes
23 May 2014 Results/Dividend Yes
23 May 2014 Results Yes
8 Feb 2014 Results Yes

Corporate Announcements

All 57 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
21 Sep 2026 AGM/EGM Kovai Medical Center & Hospital Ltd - 523323 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
19 Sep 2026 Insider Trading / SAST Kovai Medical Center & Hospital Ltd - 523323 - Closure of Trading Window
5 Dec 2014 Disclosure under Insider Trading Regulation Kovai Medical Center & Hospital Limited has informed the Exchange the details of change in the shareholding of Dr. Thavamani Devi Palaniswami (Purchase of 300 shares), in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992. The Company has further submited to the Exchange the disclosure received from Dr. Thavamani Devi Palaniswami , in terms of Regulations 13(4),13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992, for the above transaction. (Source MSE)
17 Oct 2014 Annual General Meeting Updates Kovai Medical Center & Hospital Limited has submitted to the Exchange the Proceedings of the 28th Annual General Meeting of the Company held on 3rd September 2014, along with a copy of Chariman's Speech delivered at that meeting (Source MSE)
9 Sep 2014 Dividend Updates Kovai Medical Center & Hospital Limited has informed the Exchange that the shareholders of the Company, at the Annual General Meeting held on 3rd September 2014, approved the final dividend @ 15% (Rs.1.50 per share) on the equity capital of the Company for the financial year 2013-14. The Company has further informed that the dividend will be paid / despatched to the shareholders on or before 2nd October 2014. (Source MSE)
9 Sep 2014 Disclosure of Voting Pattern - Clause 35A Kovai Medical Center & Hospital Limited has informed the Exchange the details of voting results in respect of the resolutions placed at the Annual General Meeting of the Company on 3rd September 2014, in terms of Clause 35A of the Listing Agreement The Company has further submitted the Scrutinizers Report �n this regard. (Source MSE)
9 Sep 2014 Disclosure under Insider Trading Regulation Kovai Medical Center & Hospital Limited has informed the Exchange the details of change in shareholding of Mr. S. Karthikeyan (purchase of 500 equity shares of the Company), in terms of Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations 1992. The Company has also forwarded the Disclosure received from Mr. S. Karthikeyan, the acquirer, in terms of Regulations 13(4) & 13(4A) of SEBI (Prohibition of Insider Trading) Regulations 1992. (Source MSE)
3 Sep 2014 Disclosure under SEBI Takeover Regulations M/s. Kovai Purani Finance Pvt. Ltd. has submitted to the Exchange the Disclosure in terms of Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011, in respect of acquisition of 32,72,462 Equity shares of the Company. (Source MSE)
3 Sep 2014 Discl. under SEBI Insider Trading and Takeover Regulation Kovai Medical Center & Hospital Limited has informed the Exchange the details of change in shareholding of M/s. Kovai Purani Finance Pvt. Ltd., (purchase of 32,72,462 Equity shares of the Company), in terms of Regulation 13(6) of SEBI (Prohibiion of Insider Trading) Regulations 1992. The Company has also forwarded the Disclosures received from M/s. Kovai Purani Finance Pvt. Ltd., the acquirer, in terms of Regulations 13(4) and (4A) of SEBI (Prohibiion of Insider Trading) Regulations 1992 and Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011. (Source MSE)
3 Sep 2014 Discl. under SEBI Insider Trading and Takeover Regulation Kovai Medical Center & Hospital Limited has informed the Exchange the details of change in shareholding of Dr. Mohan S. Palaniswami (sale of 8,39,769 Equity shares of the Company), in terms of Regulation 13(6) of SEBI (Prohibiion of Insider Trading) Regulations 1992. The Company has also forwarded the Disclosures received from Dr. Mohan S. Palaniswami, the seller, in terms of Regulations 13(4) and (4A) of SEBI (Prohibiion of Insider Trading) Regulations 1992 and Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011. (Source MSE)

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.28)
  • Comfortable interest coverage (12.0x)
  • Strong revenue growth YoY (15.3%)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Kovai Medical Center & Hospital Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.